Critical care
are simply unable to reposition themselves voluntarily and regularly. This prolonged, unrelieved pressure restricts blood flow to the overlying skin and underlying tissues. This restriction leads to tissue ischemia, a state of oxygen deprivation that results in tissue necrosis – the death of cells and tissues.
The duration of this unrelieved pressure is a critical determinant of the extent and severity of tissue damage. Even relatively short periods of sustained pressure, particularly in individuals with compromised circulation, can lead to irreversible tissue harm. Repositioning schedules are a standard practice in ICUs; however, their effectiveness relies heavily on strict adherence by nursing staff and, even with meticulous implementation, may prove insufficient for patients at extremely high risk of PU development. The physiological instability, which is a hallmark of critically ill patients in the ICU, further exacerbates the risk of pressure-induced tissue damage. Conditions such as sepsis, septic shock and cardiogenic shock, all of which compromise cardiovascular function, significantly impair tissue perfusion. This reduced blood flow makes the skin and underlying tissues markedly more susceptible to pressure-related injury. Vasopressor medications, frequently used to maintain adequate blood pressure in critically ill patients, can further reduce peripheral blood flow, potentially contributing to tissue hypoxia and increasing the risk of ulceration. Continuous monitoring of vital signs, including blood pressure, heart rate, oxygen saturation and indicators of tissue perfusion, such as capillary refill time and skin temperature, is crucial for identifying patients at increased risk and tailoring preventative interventions accordingly. Beyond circulatory compromise, respiratory dysfunction – another common problem for ICU patients – can contribute significantly to PU development. Hypoxia, a state of inadequate oxygen delivery to the tissues, directly impairs cellular metabolism and viability, hindering the skin’s ability to withstand pressure and delaying wound healing should an ulcer develop. Mechanical ventilation, while a life-saving intervention for patients with respiratory failure, can increase the risk of PUs due to prolonged immobility and the potential for pressure from the ventilator tubing, mask interfaces and endotracheal tube securing devices. Careful attention to securing these devices, using appropriate padding and pressure-relieving materials, and regularly assessing the skin beneath them is essential to minimise this risk.
Malnutrition, often present and frequently overlooked in critically ill patients, significantly weakens the skin’s resilience and its inherent ability to resist pressure- related damage. Protein-calorie malnutrition, in particular, impairs collagen synthesis, a crucial process for maintaining the skin’s tensile strength and structural integrity. This reduction in collagen makes the skin more fragile and susceptible to breakdown. Deficiencies
Practical Patient Care /
www.practical-patient-care.com
in essential micronutrients, such as vitamin C, zinc and copper, all of which play vital roles in wound healing and tissue repair, further compromise tissue integrity and increase the risk of ulceration. A comprehensive nutritional assessment and adequate nutritional support are, therefore, integral components of any effective PU prevention strategy. This often requires a multidisciplinary approach, involving registered dietitians, nurses and physicians, working collaboratively to optimise the patient’s nutritional intake, whether through oral feeding, tube feeding or intravenous feeding.
Multifaceted preventative strategies Effective PU prevention in the complex and demanding environment of the ICU extends far beyond the traditional practice of simply repositioning the patient at regular intervals. While regular turning remains a fundamental and essential element of any prevention protocol, a comprehensive, multifaceted approach, incorporating pressure redistribution, meticulous skin care, optimal nutritional support and continuous, vigilant monitoring, is required to minimise the risk of these devastating complications.
Pressure-redistributing support surfaces are a cornerstone of modern PU prevention strategies. Standard hospital mattresses, typically designed for comfort and general support, are generally inadequate for providing sufficient pressure relief for high-risk, immobile patients. Dynamic support surfaces, such as alternating pressure mattresses and overlays, actively and dynamically redistribute pressure by cyclically inflating and deflating a series of air cells within the mattress or overlay. These mattresses and overlays are used by a number of NHS trusts throughout the UK. These devices have been consistently shown in numerous clinical studies to be significantly more effective than static surfaces, such as standard foam mattresses, in reducing the incidence of PUs, particularly in high-risk populations. In a 2020 study by the National Institute for Health and Care Research, it was found that Grade 2 PUs took on average 18 days to develop on an alternating pressure mattress as compared to 12 days on regular hospital mattresses – an improvement of 50%. Additionally, low-air-loss mattresses provide a constant flow of air through small perforations in the mattress surface, helping to keep the skin dry and cool, which is particularly beneficial for patients with moisture-related skin problems. Heel protection devices, such as specialised boots, pillows, foam wedges or heel protectors, are essential for preventing heel ulcers, a common and often very difficult-to-treat complication, particularly in patients with compromised circulation or peripheral neuropathy. Regular skin assessments, ideally performed at least once per nursing shift and more frequently for patients identified as being at very high risk, are vital for the early detection of any signs of pressure damage.
35
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45
